CA

Charles Allerson

Chief Technology Officer

Switch Therapeutics

South San Francisco, California


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Switch Therapeutics
Industry
research
Employees
36.0
Seniority
C suite
Annual Revenue
450000.0
Total Funding
75270993.0
Latest Funding
Series A

Technologies

Mimecast Outlook Microsoft Office 365 reCAPTCHA Google Tag Manager WordPress.org Mobile Friendly Vimeo Remote

Keywords

biotechnology research rnai therapies cns diseases biomarker-gated genetic medicines sirna conditionally activated self-delivery targeted knockdown precision medicine cns pipeline neurodegenerative diseases gene therapy therapeutic applications apolipoprotein e tau pathology microglia long duration small interfering rna cell selectivity therapeutic window casi platform rna interference neuroinflammation therapeutic improvements central nervous system biotechnology molecular therapeutics drug discovery clinical development scientific collaboration innovative medicines disease targeting biodistribution ligands research & development next generation therapeutics pharmaceutical collaborations effective self-delivery biopharmaceuticals therapeutic candidates biomarker discovery rna payloads modular sensor biotechnology company biophysics therapeutic modalities innovative treatment clinical trials scientific innovation drug modalities health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans